Alzheimer’s Disease Pipeline

EP: 1.Apolipoprotein E4 in Alzheimer’s Disease

EP: 2.Importance of Early Diagnosis of Alzheimer’s Disease

EP: 3.Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease

EP: 4.Amyloid Cascade Hypothesis of Alzheimer’s Disease

EP: 5.Contribution of Multiple Pathways to the Development of Alzheimer’s Disease

EP: 6.Utilization of Neuroimaging in Alzheimer’s Disease

EP: 7.CSF Testing and Blood-based Biomarkers in Alzheimer’s Disease

EP: 8.Utilization of APOE4 Genotype in Management of Alzheimer’s Disease

Now Viewing

EP: 9.Alzheimer’s Disease Pipeline

EP: 10.The Future Outlook for Alzheimer’s Disease

Video content above is prompted by the following question:

• Please provide an overview of robust Alzheimer’s pipeline and many disease modifying therapies under investigation.
• Discuss novel and emerging treatments that are most advanced in clinical studies or have promising data:
  • Valiltramiprosate (ALZ-801,inhibits amyloid oligomer formation, oral)
  • ALN-APP (RNAi therapeutic)
  • Blarcamesine (sigma-1 and muscarinic receptors ligand)